HYPER CORPORATION INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,482 KRW | +1.30% |
|
-1.85% | +50.76% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2019 | 17.41B 12.89M 17.53M | Sales 2020 | 31.41B 23.25M 31.63M | Capitalization | 148B 110M 149M |
|---|---|---|---|---|---|
| Net income 2019 | -1.78B -1.32M -1.79M | Net income 2020 | -3.52B -2.61M -3.55M | EV / Sales 2019 | 7.38 x |
| Net cash position 2019 | 9.93B 7.35M 10M | Net cash position 2020 | 10.9B 8.07M 10.98M | EV / Sales 2020 | 4.37 x |
| P/E ratio 2019 |
-78.3
x | P/E ratio 2020 |
-39.8
x | Employees | 33 |
| Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 61.48% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.30% | ||
| 1 week | -1.85% | ||
| Current month | +0.14% | ||
| 1 month | +16.33% | ||
| 3 months | +1.79% | ||
| 6 months | +43.74% | ||
| Current year | +50.76% |
1 week
1 375.00
1 526.00
1 month
1 241.001 592.00
Current year
956.001 697.00
1 year
920.002 565.00
3 years
920.004 675.00
5 years
920.006 600.00
10 years
920.009 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sang-Woo Kim
CEO | Chief Executive Officer | 51 | - |
Gwi-Yeon Moon
AUD | Comptroller/Controller/Auditor | 57 | - |
Sung-Joon Shin
PRN | Corporate Officer/Principal | 57 | 18-03-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sang-Woo Kim
CEO | Chief Executive Officer | 51 | - |
Se-Hoon Park
BRD | Director/Board Member | 52 | - |
Myung-Woo Lee
BRD | Director/Board Member | 42 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 1,482 | +1.30% | 320,193 |
| 24-05-16 | 1,463 | +1.39% | 334,582 |
| 24-05-14 | 1,443 | -4.12% | 355,106 |
| 24-05-13 | 1,505 | -0.33% | 244,202 |
| 24-05-10 | 1,510 | -0.07% | 669,685 |
End-of-day quote Korea S.E., May 16, 2024
More quotes
Hyper Corporation Inc, formerly Medifron DBT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of information and communication devices. The Company operates through three segments. The Information and Communication Technology Business segment is engaged in the manufacture and sale of gaming mice, gaming monitors, televisions, routers, and gaming devices. The Home Meal Replacement segment is engaged in the manufacture and supply of convenient meals. The New Drug Business segment is engaged in the development and sales of Alzheimer's treatments, non-narcotic painkillers, and early diagnosis kits for dementia.
Sector
Computer Hardware
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +50.76% | 91.85M | |
| +95.45% | 107B | |
| +3.66% | 30.52B | |
| +5.18% | 23.21B | |
| +11.60% | 20.01B | |
| -6.41% | 16.25B | |
| +3.31% | 13.93B | |
| +5.41% | 11.9B | |
| +17.38% | 10.79B | |
| +13.59% | 9.98B |
- Stock Market
- Equities
- A065650 Stock
